Category Archives: Stock Fraud

Featured Stories

Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings

Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

Retailers Accused of Selling Fraudulent Herbal Supplements

Major Retailers Accused of Selling Fraudulent Herbal Supplements

The NYS attorney general’s office has accused four national retailers of selling fraudulent dietary supplements.

Read More

Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

Mortgage Securities Still Being Rubber-Stamped by Ratings Agencies

Ratings agencies, like Standard & Poor’s, are still having issues when it comes to rating complex < "http://www.yourlawyer.com/topics/overview/Mortgage-Backed-Re-Remic-Rating-Agency-Securities-Fraud-Lawyer-Lawsuit-Attorney">mortgage backed securities, according a new ProPublica report. The failure of ratings agencies like Standard & Poor’s to properly rate mortgage securities played … Continue reading

Posted in Stock Fraud |

New SEC Whistleblower Rules Spur Fraud Complaints

The Dodd-Frank Wall Street Reform and Consumer Protection Act was passed by the US Congress and signed by President Obama earlier this summer and contains some very attractive incentives for securities fraud whistleblowers.Now, according to the US Securities and Exchange … Continue reading

Posted in Stock Fraud, Whistleblower |

Big Payoffs Possible for Securities Fraud Whistleblowers Thanks to “Wall Street Tip-Off Law”

The Dodd-Frank Act, passed by the US Congress and signed by President Obama earlier this summer, contains some attractive incentives for securities fraud whistleblowers. The law empowers the U.S. Securities and Exchange Commission (SEC) and the Commodities Futures Trading Commission … Continue reading

Posted in Stock Fraud, Whistleblower |

Madoff Family Targeted in $30 Million Lawsuit

Irving Picard, the court-appointed trustee who has been working to recover the billions of dollars lost in the historic < "http://www.yourlawyer.com/topics/overview/Bernard_Madoff_Investment_fraud">Bernard Madoff Ponzi scheme, has just filed three lawsuits, said The Associated Press (AP). Madoff, 72, pleaded guilty to running … Continue reading

Posted in Stock Fraud |

SEC Announces Record Settlement with Goldman Sachs

Goldman Sachs has agreed to pay a record $550 million to settle civil securities fraud allegations with the U.S. Securities and Exchange Commission (SEC). The settlement, which still has to be approved by a judge, is the largest penalty a … Continue reading

Posted in Stock Fraud |

Conspiracy Eyed in Madoff Case

When Bernard Madoff pleaded guilty to running the biggest Ponzi scheme in history, he claimed that he acted alone and no one—no family members, friends, or colleagues—were aware of his fraud, said ProPublica. Madoff is now spending 150 years in … Continue reading

Posted in Stock Fraud |

Senate Takes Aim at Credit Rating Agency Conflicts

The U.S. Senate has approved an amendment to its financial reform bill aimed at preventing conflicts of interest between credit rating agencies and investment banks. If it becomes law, the amendment would prevent investment banks from shopping around among credit … Continue reading

Posted in Stock Fraud |

New York AG Subpoenas Investment Banks, Ratings Agencies

New York Attorney General Andrew Cuomo has reportedly opened an investigation into the relationship between Wall Street and investment rating agencies. According to a Bloomberg report, Cuomo’s office is trying to ascertain whether or not the banks misled the agencies … Continue reading

Posted in Stock Fraud |

Goldman Sachs, SEC Said to Be In Settlement Talks

Goldman Sachs has apparently entered settlement talks with the Securities and Exchange Commission (SEC) to settle civil fraud charges the agency levied against the investment bank last month. According to a Wall Street Journal report, the talks didn’t include any … Continue reading

Posted in Stock Fraud |

Goldman Sachs Named in Shareholder Lawsuits

We have been following the Goldman Sachs debacle since news broke regarding the investment bank’s mortgage securities deals. Now, The Washington Post is reporting the financial giant just announced that six private lawsuits have been filed alleging “breach of fiduciary … Continue reading

Posted in Stock Fraud |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.